This Practice Note covers the factors to be considered when trade marking pharmaceuticals, as well as other rules governing the naming and branding of pharmaceuticals. It also considers the repackaging of pharmaceuticals and address specific issues relating to counterfeit medicines and the practicalities of identification and seizure by customs.